ImmuCell Corporation (ICCC) Open Interest History

Open interest tracks the total number of outstanding options contracts. Rising OI alongside price moves can indicate growing commitment to the trend; declining OI suggests positions are being closed.

ImmuCell Corporation (ICCC) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $89.9M, listed on NASDAQ, employing roughly 73 people, carrying a beta of 0.57 to the broader market. ImmuCell Corporation functions as an animal health enterprise, specializing in the creation, manufacturing, and commercialization of offerings aimed at improving the vitality and output of dairy and beef cattle, serving both the U. Led by F. Olivier Te Boekhorst, public since 1987-05-05.

Open interest history tracks how outstanding options contracts change over time. No recent options activity for ICCC as of 2026-08-31; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how open interest is reported and how to read the data →